期刊文献+

hTSHR胞膜外区片段真核表达载体的构建和表达

Construction and expression of the eukaryotic expression plamids of human TSHR extracellular domain
下载PDF
导出
摘要 目的:构建人类促甲状腺激素受体(hTSHR)胞膜外区氨基端的两个片段hTSHRf(aa29-100)、hTSHRe(aa101-278)的真核表达载体pcDNA3.1-hTSHRf和pcDNA3.1-hT-SHRe,并在CHO细胞中进行表达。方法:RT-PCR法从人甲状腺正常组织的cDNA中扩增hTSHRf和hTSHRe,定向插入真核表达载体pcDNA3.1(D)/V5-His-TOPO中,经酶切、PCR和测序鉴定后通过脂质体介导转染至CHO细胞中进行表达,RT-PCR扩增转染细胞的cDNA、Western blot分别鉴定hTSHR在CHO细胞中mRNA和蛋白水平的表达。结果:RT-PCR分别扩增两个片段的阳性克隆株,所得片段大小与预期一致,经Western blot鉴定,相对分子质量(Mr)分别为11900、23600左右,与预期的大小相符。结论:真核表达载体pcDNA3.1-hTSHRf和pcDNA3.1-hTSHRe构建成功,RT-PCR和Western blot检测证实重组质粒能在CHO细胞中高效表达,为进一步研究pcDNA3.1-hTSHRf和pcDNA3.1-hTSHRe在体内的基因表达,建立Graves'病的动物模型奠定了基础。 AIM: To construct the eukaryotic expression plamids of hTSHR extracellular domain and study their expression in CHO cells.METHODS: The human TSHR extracellular domain cDNAs,which were 188-403 bp and 407-904 bp,were amplified from human normal thyroid by RT-PCR.Two fragments were inserted intopcDNA3.1(D)/V5-His-TOPO.Then the recombinant plasmids pcDNA3.1-hTSHRf and pcDNA3.1-hTSHRe were transfected into CHO cells by Lipofectin after they were identified by restricting enzyme Hind Ⅲ digestion analysis,PCR amplifying and DNA sequencing.RT-PCR and Western blot analysis were used to analyse hTSHR expression on mRNA and at protein levels.RESULTS: Two bands of 220 bp and 540 bp were amplified from CHO cells transfected by the recombinant plamids pcDNA3.1-hTSHRf and pcDNA3.1-hTSHRe,respectively.Western blot analysis revealed that CHO cells transfected by pcDNA3.1-hTSHRf and pcDNA3.1-hTSHRe had strong bands with molecular weight of about 11 900 and 23 600,respectively.CONCLUSION: The recombinant plasmids have been successfully constructed.The transcription on CHO cells transfected by the recombinant plasmids has been proved by RT-PCR and eukaryotic expression has been confirmed by Western blot analysis.Our research will contribute to further study on gene expression in vivo and the establishment of animal models of Graves' disease.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第8期785-787,790,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30370682) 天津市科技发展计划项目资助(05YFGDSF02700)
关键词 TSH受体 真核表达 Graves’病 TSHR eukaryotic expression Graves' disease
  • 相关文献

参考文献12

  • 1Rocchi R. Clinical utility of autoantibodies directed against TSH-R [J]. MLO Med Lab Obs, 2005, 37(4): 10-11, 14-15.
  • 2Davies TF, Ando T, Lin RY, et al. Thyrotropin receptor-associated diseases: from adenomata to Graves'disease [ J ]. J Clin Invest, 2005, 115(8) : 1972 - 1983.
  • 3马海蓉,孙怡,雷卫祺,陈双,马艳,赵民安,曹旭.hBPI与EGFP融合蛋白真核表达载体的构建及其在MCF-7细胞中的表达和定位[J].细胞与分子免疫学杂志,2007,23(9):876-879. 被引量:2
  • 4奥斯伯 F M,金斯顿 R E,赛德曼 J G,等.精编分子生物学实验指南[M].4版.马学军,舒跃龙,颜子颖,等译.北京:科学出版社,2005:104-106.
  • 5McLachlan SM, Nagayama Y, Rapopoa B. Insight into Graves' hyperthyroidism from animal models [ J ]. Endocr Rev, 2005, 26 ( 6 ) : 800 - 832.
  • 6Nagayama Y. Animal models of Graves' hyperthyroidism[J]. Endocr J, 2005, 52(4) : 385 -394.
  • 7Kaneda T, Honda A, Hakozaki A, et al. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice[ J]. Endocrinology, 2007, 148(5) : 2335 -2344.
  • 8Kim WB, Chung HK, Park Y J, et al. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease[J]. Thyroid, 2000, 10(7) : 579 -586.
  • 9Pichurin P, Yah XM, Farilla L, et al. Naked TSH receptor DNA vaccination: A TH1 T cell response in which interferon-γ production, rather than antibody, dominates the immune response in mice [ J]. Endocrinology, 2001, 142(8): 3530-3536.
  • 10Tahara K, Ishikawa N, Yamamoto K, et al. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor[J]. Thyroid, 1997, 7(6): 867-77.

二级参考文献20

  • 1陆凤先,戴承恺,叶静,汤特,王伟.TSH受体活性片段反义肽的免疫调节作用[J].中华内分泌代谢杂志,2004,20(4):349-352. 被引量:6
  • 2曹珊珊,吴开春,颜真,万一,韩宇,赵丽娜,樊代明.重组融合蛋白GX1-rmhTNFα的克隆、表达及鉴定[J].细胞与分子免疫学杂志,2006,22(3):360-362. 被引量:10
  • 3Weetman AP.Autoimmune thyroid disease:Propagation and progression[J].EurJ Endocrinol,2003,148 (1):1
  • 4Davies TF,Ando T,Lin RY,et al.Thyrotropin receptor-associated diseases:from adenomata to Graves disease[J].J Clin Invest,2005,115(8):1 972
  • 5Davies T,Marians R,Latif R.The TSH receptor reveals itself[J].J Clin Invest,2002,110(2):161
  • 6Ludgate M.Animal model of Graves' disease[J].Eur J Endocrinol,2000,142(1):1
  • 7Akamizu T,Moriyama K,Miura M,et al.Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TRAbs) derived from lymphocytes of patients with Graves' disease:epitope and binding study of two stimulatory TRAbs[J].Endocrinology,1999,140(4):1 594
  • 8Seetharamaiah GS,Dallas JS,Prabhakar BS.Glycosylated ectodomain of the human thyrotropin receptor induces antibodies capable of reacting with multiple blocking antibody epitopes[J].Autoimmunity,1999,29(1):21
  • 9Schwarz-lauer L,Chazenbalk GD,Mclachlan SM,et al.Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor[J].Thyroid,2002,12(2):115
  • 10Chen CR,Pichurin P,Chazenbalk GD,et al.Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease[J].Endocrinology,2004,145(1):228

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部